Brief: Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59
23/07/2026 20:01
BRIEF-Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59 Jul 23 (Reuters) - Embecta outlook FY revenue USD 1,015-1,035 million vs. IBES estimate USD 1,021 million.
Recent news on Embecta
See all newsEmbecta Corp. reports results for the quarter ended June 30 - Earnings Summary
Brief: Embecta Reports Third Quarter Fiscal 2026 Financial Results
Brief: Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel